FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 3143011 · Received May 23, 2013

Report

Report Number
2953161-2013-00075
Event Type
Injury
Date Received
May 23, 2013
Date of Event
April 29, 2013
Report Date
April 29, 2013
Manufacturer
W. L. GORE & ASSOCIATES, INC.
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS - THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. CONCLUSIONS - THE ROOT CAUSE OF THE AORTIC RUPTURE COULD NOT BE DETERMINED WITH THE PROVIDED INFORMATION. REFER TO THE FOLLOWING MEDWATCH NUMBERS FOR INFORMATION ON ADDITIONAL DEVICES INVOLVED IN THIS EVENT. MEDWATCH# 2017233-2013-00331 CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS. MEDWATCH# 2017233-2013-00332 GORE TRI-LOBE BALLOON CATHETER.

Description of Event or Problem · 1

ON (B)(6) 2013, THE PATIENT WAS IMPLANTED WITH A CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS TO TREAT AN INFRARENAL ABDOMINAL AORTIC ANEURYSM. A CONTRALATERAL LEG COMPONENT WAS ALSO IMPLANTED 3 CM ABOVE THE AORTIC BIFURCATION AND EXTENDED INTO THE COMMON ILIAC ARTERY. DURING BALLOONING OF THE TAG DEVICE, THE AORTA RUPTURED. IT WAS REPORTED THE RUPTURE WAS EITHER DUE TO OVER INFLATION OF THE BALLOON OR BALLOONING IN THE PATIENT'S FRIABLE AORTA. AN AORTIC EXTENDER COMPONENT WAS IMPLANTED IN AN ATTEMPT TO REPAIR THE RUPTURE, BUT BALLOONING OF THIS GRAFT REPORTEDLY RESULTED IN MORE BLEEDING. AT THIS POINT, THE PHYSICIAN ELECTED TO CONVERT THE PATIENT TO OPEN REPAIR AND TREAT THE RUPTURE SURGICALLY. IT WAS REPORTED THE PATIENT TOLERATED THE OPEN CONVERSION PROCEDURE WITH NO FURTHER ADVERSE EVENTS BEING REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
228058 GORE EXCLUDER AAA ENDOPROSTHESIS MIH W. L. GORE & ASSOCIATES, INC. 8684170

Patients

Seq Age Sex Outcome Treatment
1 81 YR Hospitalization| R GLIPIZIDE| LIPITOR| HYDROCHLOROTHIAZIDE| ASPIRIN| ATENOLOL| POTASSIUM| ZANTAC